Key points are not available for this paper at this time.
The flow cytometric analysis of cells from patients with known or suspected hematological malignancy encompasses issues of specimen triage (is the test necessary?), technology (actual laboratory performance of the test), medical interpretation (analysis of technical data in the medical context of the patient), and reporting of the results in a manner meaningful to the treating physician.
Stelzer et al. (Wed,) studied this question.